Reaction
Gastric Varices reporting signals
As of the last recalculation, Gastric Varices appears in 458 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 53.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tenofovir Disoproxil Fumarate Tablets | 10 | 53.8 | 53.8 |
| Ado-Trastuzumab Emtansine | 9 | 49.5 | 49.5 |
| Rifaximin | 15 | 33.6 | 33.6 |
| Lamivudine Oral | 14 | 25.9 | 25.9 |
| Nevirapine | 5 | 25.5 | 25.5 |
| Obinutuzumab | 9 | 25.3 | 25.4 |
| Efavirenz | 6 | 24.8 | 24.8 |
| Selexipag | 13 | 23.5 | 23.5 |
| Azacitidine For | 9 | 22.9 | 22.9 |
| Oxaliplatin | 31 | 20.3 | 20.3 |
| Entecavir | 5 | 19.7 | 19.7 |
| Atezolizumab | 16 | 19.4 | 19.4 |
| Tenofovir Disoproxil Fumarate | 13 | 18.4 | 18.4 |
| Sofosbuvir | 7 | 16.4 | 16.4 |
| Fam-Trastuzumab Deruxtecan-Nxki | 3 | 13.6 | 13.6 |